UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Rivaroxaban in Peripheral Artery Disease after Revascularization

The New England journal of medicine, 2020-05, Vol.382 (21), p.1994-2004

2020

Link zum Volltext

Verfügbarkeit prüfen

Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial

The American heart journal, 2022-04, Vol.246, p.136-143

2022

Link zum Volltext

Verfügbarkeit prüfen

Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet

The American journal of clinical nutrition, 2010-03, Vol.91 (3), p.578-585

2010

Link zum Volltext

Verfügbarkeit prüfen

Ethical Conduct of Palliative Care Research: Enhancing Communication Between Investigators and Institutional Review Boards

Journal of pain and symptom management, 2014-12, Vol.48 (6), p.1211-1221

2014

Link zum Volltext

Verfügbarkeit prüfen

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)

The American heart journal, 2018-05, Vol.199, p.83-91

2018

Link zum Volltext

Verfügbarkeit prüfen

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative

Circulation (New York, N.Y.), 2017-06, Vol.135 (25), p.2534-2555

2017

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety

Circulation (New York, N.Y.), 2020-12, Vol.142 (23), p.2219-2230

2020

Link zum Volltext

Verfügbarkeit prüfen

Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study

The American heart journal, 2021-05, Vol.235, p.12-23

2021

Link zum Volltext

Verfügbarkeit prüfen

Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial

Journal of the American College of Cardiology, 2021-07, Vol.78 (4), p.317-326

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

Circulation (New York, N.Y.), 2021-10, Vol.144 (14), p.1104-1116

2021

Link zum Volltext

Verfügbarkeit prüfen

Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD

Circulation (New York, N.Y.), 2021-12, Vol.144 (23), p.1831-1841

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD

Journal of the American College of Cardiology, 2021-11, Vol.78 (18), p.1768-1778

2021

Link zum Volltext

Verfügbarkeit prüfen

Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial

European heart journal, 2021-10, Vol.42 (39), p.4040-4048

2021

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits

Journal of vascular surgery, 2023-04, Vol.77 (4), p.1107-1118.e2

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone

Journal of thrombosis and haemostasis, 2022-05, Vol.20 (5), p.1193-1205

2022

Link zum Volltext

Verfügbarkeit prüfen

Should Participants in Clinical Trials Be Able to Withdraw from Passive Follow‐Up?

Ethics & human research, 2021-01, Vol.43 (1), p.32-36

2021

Link zum Volltext

Verfügbarkeit prüfen

Exercise Training and Revascularization in the Management of Symptomatic Peripheral Artery Disease

JACC. Basic to translational science, 2021-02, Vol.6 (2), p.174-188

2021

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization

JAMA network open, 2022-06, Vol.5 (6), p.e2215580-e2215580

2022

Link zum Volltext

Verfügbarkeit prüfen

A randomized trial of heart failure disease management in skilled nursing facilities (SNF Connect): Lessons learned

Clinical trials (London, England), 2017-06, Vol.14 (3), p.308-313

2017

Link zum Volltext

Verfügbarkeit prüfen

Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance

Journal of lipid research, 2003-06, Vol.44 (6), p.1174-1181

2003

Link zum Volltext

Verfügbarkeit prüfen

Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations

Journal of clinical lipidology, 2007-12, Vol.1 (6), p.626-633

2007

Link zum Volltext

Verfügbarkeit prüfen

Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia

Arteriosclerosis, thrombosis, and vascular biology, 2003-02, Vol.23 (2), p.307

2003

Link zum Volltext

Verfügbarkeit prüfen

EFFICACY AND SAFETY OF RIVAROXABAN IN ELDERLY PATIENTS WITH SYMPTOMATIC PAD UNDERGOING REVASCULARIZATION: INSIGHTS FROM VOYAGER PAD

Journal of the American College of Cardiology, 2021-05, Vol.77 (18), p.1783-1783

2021

Link zum Volltext

Verfügbarkeit prüfen

Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase

American journal of physiology: endocrinology and metabolism, 2010-10, Vol.299 (4), p.E576-E583

2010

Link zum Volltext

Verfügbarkeit prüfen

Severe hypertriglyceridemia with a history of treatment failure

Nature clinical practice. Endocrinology & metabolism, 2005-11, Vol.1 (1), p.53-58

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(19)
Cardiovascular System & Cardiology
(16)
Cardiac & Cardiovascular Systems
(12)
Male
(11)
Female
(10)
Middle Aged
(9)
Peripheral Vascular Disease
(8)
Rivaroxaban
(7)
Biological And Medical Sciences
(6)
Peripheral Arterial Disease - Surgery
(6)
Thrombosis
(6)
Adult
(5)
Aged
(5)
Peripheral Arterial Disease - Drug Therapy
(5)
Peripheral Artery Disease
(5)
Revascularization
(5)
Anticoagulants
(4)
Aspirin
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rivaroxaban in Peripheral Artery Disease after Revascularization

Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial

Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet

Ethical Conduct of Palliative Care Research: Enhancing Communication Between Investigators and Institutional Review Boards

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative

Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety

Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study

Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD

Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD

Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial

Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone

Should Participants in Clinical Trials Be Able to Withdraw from Passive Follow‐Up?

Exercise Training and Revascularization in the Management of Symptomatic Peripheral Artery Disease

Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization

A randomized trial of heart failure disease management in skilled nursing facilities (SNF Connect): Lessons learned

Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance

Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations

Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia

EFFICACY AND SAFETY OF RIVAROXABAN IN ELDERLY PATIENTS WITH SYMPTOMATIC PAD UNDERGOING REVASCULARIZATION: INSIGHTS FROM VOYAGER PAD

Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase

Severe hypertriglyceridemia with a history of treatment failure

Suchergebnisse filtern